Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6971575rdf:typepubmed:Citationlld:pubmed
pubmed-article:6971575lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:6971575lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6971575lifeskim:mentionsumls-concept:C0004561lld:lifeskim
pubmed-article:6971575lifeskim:mentionsumls-concept:C0041385lld:lifeskim
pubmed-article:6971575lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:6971575lifeskim:mentionsumls-concept:C1515926lld:lifeskim
pubmed-article:6971575pubmed:issue1lld:pubmed
pubmed-article:6971575pubmed:dateCreated1981-6-13lld:pubmed
pubmed-article:6971575pubmed:abstractTextThe ultrastructure of three human lymphoblastoid B cell lines, Raji, RPMI 4098, and WIL-2, was analyzed after the cells were incubated with tunicamycin, and antibiotic that selectively inhibits N-linked glycosylation of macromolecules. After a 24-hour exposure to 1.0 microgram/ml of tunicamycin, the lymphocytes lose their microvilli and become smooth spheres or develop a few blebs. Also, the cells show a dilation of the endoplasmic reticulum and an increase in myelin figures resulting from intracellular membrane accumulation, possibly lysosomal in origin. These ultrastructural alterations are similar to those observed in Tay-Sachs, Fabrey's, and Gaucher's diseases, Type II pneumocytes in viral pneumonitis, certain lysosomal storage diseases, and in aging fibroblasts. Therefore, tunicamycin-treated cells may be a useful model in the correlation of altered ultrastructural pattern in membrane flow with the etiology of certain diseases.lld:pubmed
pubmed-article:6971575pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:languageenglld:pubmed
pubmed-article:6971575pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:citationSubsetAIMlld:pubmed
pubmed-article:6971575pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6971575pubmed:statusMEDLINElld:pubmed
pubmed-article:6971575pubmed:monthAprlld:pubmed
pubmed-article:6971575pubmed:issn0002-9440lld:pubmed
pubmed-article:6971575pubmed:authorpubmed-author:FerroneSSlld:pubmed
pubmed-article:6971575pubmed:authorpubmed-author:GlassyM CMClld:pubmed
pubmed-article:6971575pubmed:issnTypePrintlld:pubmed
pubmed-article:6971575pubmed:volume103lld:pubmed
pubmed-article:6971575pubmed:ownerNLMlld:pubmed
pubmed-article:6971575pubmed:authorsCompleteYlld:pubmed
pubmed-article:6971575pubmed:pagination1-9lld:pubmed
pubmed-article:6971575pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:6971575pubmed:meshHeadingpubmed-meshheading:6971575-...lld:pubmed
pubmed-article:6971575pubmed:meshHeadingpubmed-meshheading:6971575-...lld:pubmed
pubmed-article:6971575pubmed:meshHeadingpubmed-meshheading:6971575-...lld:pubmed
pubmed-article:6971575pubmed:meshHeadingpubmed-meshheading:6971575-...lld:pubmed
pubmed-article:6971575pubmed:meshHeadingpubmed-meshheading:6971575-...lld:pubmed
pubmed-article:6971575pubmed:meshHeadingpubmed-meshheading:6971575-...lld:pubmed
pubmed-article:6971575pubmed:meshHeadingpubmed-meshheading:6971575-...lld:pubmed
pubmed-article:6971575pubmed:meshHeadingpubmed-meshheading:6971575-...lld:pubmed
pubmed-article:6971575pubmed:meshHeadingpubmed-meshheading:6971575-...lld:pubmed
pubmed-article:6971575pubmed:meshHeadingpubmed-meshheading:6971575-...lld:pubmed
pubmed-article:6971575pubmed:meshHeadingpubmed-meshheading:6971575-...lld:pubmed
pubmed-article:6971575pubmed:year1981lld:pubmed
pubmed-article:6971575pubmed:articleTitleUltrastructural alterations in human lymphoblastoid B cell lines treated with tunicamycin.lld:pubmed
pubmed-article:6971575pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6971575pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6971575lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6971575lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6971575lld:pubmed